TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Orifarm Generics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
579,343
|
487,758
|
495,016 |
Financial expenses |
281
|
484
|
1,072 |
Earnings before taxes |
11,330
|
12,755
|
11,884 |
EBITDA |
10,139
|
8,536
|
12,330 |
Total assets |
150,322
|
110,637
|
79,919 |
Current assets |
143,615
|
104,931
|
74,711 |
Current liabilities |
119,543
|
81,731
|
61,076 |
Equity capital |
30,779
|
28,906
|
18,843 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
20.5%
|
26.1%
|
23.6% |
Turnover per employee |
193,114
|
162,586
|
165,005 |
Profit as a percentage of turnover |
2.0%
|
2.6%
|
2.4% |
Return on assets (ROA) |
7.7%
|
12.0%
|
16.2% |
Current ratio |
120.1%
|
128.4%
|
122.3% |
Return on equity (ROE) |
36.8%
|
44.1%
|
63.1% |
Change turnover |
91,585
|
-7,258
|
162,619 |
Change turnover % |
19%
|
-1%
|
49% |
Chg. No. of employees |
0
![]() |
0
|
3 |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.